Growth Metrics

Ionis Pharmaceuticals (IONS) Shareholder's Equity (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Ionis Pharmaceuticals 12.61 Bn 10.69 Bn 243.11 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.48%
Dec 31, 2025 -20.86%
Sep 30, 2025 -2.18%
Jun 30, 2025 32.79%
Mar 31, 2025 -19.14%
Dec 31, 2024 -11.19%
Sep 30, 2024 151.22%
Jun 30, 2024 -11.07%
Mar 31, 2024 -23.32%
Dec 31, 2023 22.58%
Sep 30, 2023 -26.35%
Jun 30, 2023 -11.98%
Mar 31, 2023 -15.07%
Dec 31, 2022 -3.61%
Sep 30, 2022 -4.86%
Jun 30, 2022 -11.96%
Mar 31, 2022 -8.05%
Dec 31, 2021 45.46%
Sep 30, 2021 -8.95%
Jun 30, 2021 -14.38%
Mar 31, 2021 -8.44%
Dec 31, 2020 -51.12%
Sep 30, 2020 1.20%
Jun 30, 2020 2.08%
Mar 31, 2020 -6.69%
Dec 31, 2019 5.31%
Sep 30, 2019 2.80%
Jun 30, 2019 5.03%
Mar 31, 2019 26.06%
Dec 31, 2018 31.00%
Sep 30, 2018 2.78%
Jun 30, 2018 111.17%
Mar 31, 2018 5.97%
Dec 31, 2017 1,309.58%
Sep 30, 2017 0.57%
Jun 30, 2017 0.29%
Mar 31, 2017 -176.89%
Dec 31, 2016 249.49%
Sep 30, 2016 1.32%
Jun 30, 2016 -66.63%
Mar 31, 2016 -108.03%
Dec 31, 2015 1,218.17%
Sep 30, 2015 -197.53%
Jun 30, 2015 -60.92%
Mar 31, 2015 -81.72%
Dec 31, 2014 1,425.87%
Sep 30, 2014 -31.66%
Jun 30, 2014 -14.76%
Mar 31, 2014 -92.34%
Dec 31, 2013 -5.74%
Sep 30, 2013 0.09%
Jun 30, 2013 99.45%
Mar 31, 2013 10.03%
Dec 31, 2012 7.33%
Sep 30, 2012 10.34%
Jun 30, 2012 2.28%
Mar 31, 2012 -11.99%
Dec 31, 2011 -8.24%
Sep 30, 2011 -11.97%
Jun 30, 2011 -6.80%
Mar 31, 2011 -6.89%
Dec 31, 2010 -3.61%
Sep 30, 2010 -3.25%